Areva has permission to conduct early stage tests on a new cancer treatment using lead-212, which can be extracted from industrial activities including the reprocessing of used nuclear fuel...
Read Article.
Subscribe to:
Post Comments (Atom)
Posts
Archive
-
▼
2011
(158)
-
▼
January
(33)
- Medvedev Inks New START Ratification Text
- U.S. Pushes to Advance Fissile Material Talks
- Russia Demands NATO Investigation of Stuxnet Worm
- Disarmament Deadlock Risks Proliferation, U.N. Chi...
- Chu plugs R&D to hit Obama's clean-energy target
- Nuclear power poised to help meet demands of clima...
- Measure Seen Threatening Funds for U.S. Nuclear Labs
- Areva seeks to put lead-212 in hospital
- NASA’s Hansen Presses Obama for a Carbon Cost and ...
- Oil giant Saudi Arabia looks to alternative energy
- U.S.-China Statement a Turning Point on North Korea
- Onsite used fuel storage period extended
- China and Exelon deepen ties
- Energy Sector to Parse Obama Speech for Clarity on...
- Palo Verde Brings Electricity and $1.8B to Arizona...
- French Company Designs Underwater Nuclear Plant
- Obama Ups Pressure on China to Deal With North Korea
- Iran Nuclear Deadlock Persists at Meeting
- NuScale scales back spending
- NRC panel: new reactor can withstand plane crash
- China and the U.S. sign energy deals
- Iran Talks to Focus on Fuel Swap, Nuclear Monitoring
- North Korean Actions Needed to Resume Talks: U.S.-...
- U.S., China Agree to Expand Nuclear Security Ties
- NRC Should Perform Non-Proliferation Assessment of...
- Westinghouse trails forthcoming small reactor
- Nuclear power a leader in safety
- Maintain nuclear perspective, China told
- GE Hitachi Nuclear Energy teaming up with suppliers
- Nuclear fear-mongers hinder America's energy future
- NRC: Arizona’s nuke plant OK for license renewal
- Iran's nuclear sites tour proposal flounders
- New International Nuclear-Fuel Bank Likely To Find...
-
▼
January
(33)
No comments:
Post a Comment